Evidence map›Paper›PMID 27601657›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.

Jonathan R Honegger, Dana Tedesco, Jennifer A Kohout, Mona R Prasad, Aryn A Price, Tera Lindquist, Samantha Ohmer, Melissa Moore-Clingenpeel, Arash Grakoui, Christopher M Walker

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Lymphocyte Landscape after ChronicInternational journal of molecular sciences · 2020
    Review
  6. Article
  7. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2019
    Review
  8. Genetics of the Human Interferon Lambda Region.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Human Genetic Determinants of Viral Diseases.Annual review of genetics · 2017
    Review
  13. Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jonathan R HoneggerThe Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205; Department of Pediatrics, The Ohio State University School of Medicine, Columbus, OH 43205; jonathan.honegger@nationwidechildrens.org.ORCID 0000-0002-3181-0554
Dana TedescoDivision of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
Jennifer A KohoutThe Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205;
Mona R PrasadDepartment of Obstetrics and Gynecology, The Ohio State University School of Medicine, Columbus, OH 43210;
Aryn A PriceDivision of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
Tera LindquistThe Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205;
Samantha OhmerMedical Scientist Training Program, The Ohio State University, Columbus, OH 43210; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH 43210;
Melissa Moore-ClingenpeelBiostatistics Core, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205;
Arash GrakouiDivision of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322.
Christopher M WalkerThe Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205; Department of Pediatrics, The Ohio State University School of Medicine, Columbus, OH 43205;
Nationwide Children's Hospital · USEmory University · USThe Ohio State University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
HCV-specific T cell responseR37AI047367 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WALKER, CHRISTOPHER M. · 2005 to 2014
$6.1M
Persistent hepatitis C virus replication and T cell immunity in pregnancyR01AI096882 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WALKER, CHRISTOPHER M. · 2012 to 2022
$5.7M
Mechanisms of hepatitis C virus persistenceR01AI070101 · NIAID · EMORY UNIVERSITY · PI GRAKOUI, ARASH · 2006 to 2016
$3.9M
Child Health Research Career Development AwardK12HD043372 · NICHD · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BRADY, MICHAEL THOMAS · 2003 to 2012
$3.8M
T cell Immunity and the Outcome of Acute HCV InfectionR01AI126890 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GRAKOUI, ARASH, WALKER, CHRISTOPHER M. · 2016 to 2020
$3.7M
T cell compartmentalization and antiviral responseR01AI124680 · NIAID · EMORY UNIVERSITY · PI GRAKOUI, ARASH, ZHU, CHENG · 2016 to 2020
$3.2M
NICHD Institutional Training for Pediatricians (T32)T32HD043003 · NICHD · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BARNARD, JOHN A · 2003 to 2014
$1.7M
Persistent hepatitis C virus replication and T cell immunity in pregnancyR56AI096882 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WALKER, CHRISTOPHER M. · 2011 to 2011
$611k
Host and viral determinants of hepatitis C virus macaque infectionR21AI118337 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EVANS, MATTHEW J, GRAKOUI, ARASH · 2015 to 2016
$499k
NCATS NIH HHS UL1 TR001070NCRR NIH HHS P51 RR000165NIAID NIH HHS R01 AI070101NIAID NIH HHS R01 AI096882NIAID NIH HHS R01 AI124680NIAID NIH HHS R01 AI126890NIAID NIH HHS R21 AI118337NIAID NIH HHS R37 AI047367NIAID NIH HHS R56 AI096882NICHD NIH HHS K12 HD043372NICHD NIH HHS T32 HD043003NIH HHS P51 OD011132
6 · The paper itself

Abstract

Chronic hepatitis C virus (HCV) infection is characterized by exhaustion of virus-specific T-cells and stable viremia. Pregnancy is an exception. Viremia gradually climbs during gestation but sometimes declines sharply in the months following delivery. Here, we demonstrated that postpartum HCV control was associated with enhanced virus-specific T-cell immunity. Women with viral load declines of at least 1 log10 between the third trimester and 3-mo postpartum exhibited HCV-specific T-cell responses of greater breadth (P = 0.0052) and magnitude (P = 0.026) at 3-mo postpartum than women who failed to control viremia. Moreover, viral dynamics were consistent in women after consecutive pregnancies, suggesting genetic underpinnings. We therefore searched for genetic associations with human leukocyte antigen (HLA) alleles and IFN-λ3 gene (IFNL3) polymorphisms that influence HCV infection outcome. Postpartum viral control was associated with the IFNL3 rs12979860 genotype CC (P = 0.045 at 6 mo) that predicts a positive response to IFN-based therapy. Suppression of virus replication after pregnancy was also strongly influenced by the HLA class II DPB1 locus. HLA-DPB1 alleles are classified by high and low patterns of expression. Carriage of at least one high-expression HLA-DPB1 allele predicted resurgent virus-specific T-cell immunity and viral control at 3-mo postpartum (P = 0.0002). When considered together in multivariable analysis, IFNL3 and HLA-DPB1 independently affected viral control at 3- and 6-mo postpartum. Together, these findings support a model where spontaneous control of HCV such as sometimes follows pregnancy is governed by genetic polymorphisms that affect type III IFN signaling and virus-specific cellular immune responses.

Indexed as

AdultFemaleGene Expression RegulationGenotypeHepacivirusHepatitis C, ChronicHLA-DP beta-ChainsHumansImmunity, CellularIntracellular Signaling Peptides and ProteinsMaternal-Fetal RelationsPolymorphism, Single NucleotidePostpartum PeriodPregnancyT-LymphocytesViral LoadHLA-DPB1 antigenHLA-DP beta-ChainsIFIT3 protein, humanIntracellular Signaling Peptides and Proteinshepatitis C virusHLA-DPB1IFNL3pregnancyT-cell

Identifiers

PMID27601657
PMCPMC5035892
OpenAlexW2514373122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.